ProMeris
Withdrawn
metaflumizone
Medicine
Veterinary
Withdrawn
The marketing authorisation for ProMeris has been withdrawn at the request of the marketing authorisation holder.
Treatment and prevention of flea infestations (Ctenocephalides canis and C. felis) in cats. The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).